MSOX ISSUER
The issuer of the MSOX ETF is AdvisorShares. This investment management firm specializes in creating unique exchange-traded funds, including the MSOX ETF, which aims to provide magnified exposure to the U.S. cannabis sector. AdvisorShares is known for its innovative approach to ETFs, offering both leveraged and actively managed options to meet the diverse needs of investors.
MSOX DIVIDEND
The MSOX ETF is an actively managed investment vehicle that aims to double the daily total return of the US Cannabis ETF by utilizing swap agreements. The fund's strategy is to offer leveraged exposure to the US Cannabis ETF, which primarily invests in U.S. companies generating significant revenue from the marijuana and hemp sectors. While the fund employs derivatives to magnify daily returns, it is not designed to meet its investment goals over periods longer than one day. At least 25% of the fund's assets are allocated to the Pharmaceuticals, Biotechnology & Life Sciences Industry Group within the Health Care Sector.
MSOX TRACKING
The MSOX ETF aims to provide double the daily return, before fees and expenses, of the US Cannabis ETF. It achieves this objective through swap agreements with the US Cannabis ETF, seeking to magnify its investment results. The US Cannabis ETF primarily invests in companies deriving a substantial portion of their revenue from the marijuana and hemp business in the United States, thereby offering MSOX investors amplified exposure to the evolving cannabis industry.
MSOX CORRELATION
The AdvisorShares 2x US Cannabis ETF (MSOX) seeks to deliver twice the daily return of the US Cannabis ETF by utilizing swap agreements. MSOX aims to achieve this leveraged performance on a daily basis, reflecting the returns of its affiliated ETF. The underlying US Cannabis ETF invests in companies deriving a significant portion of their revenue from the marijuana and hemp business in the United States, spanning various sectors including pharmaceuticals, biotechnology, agriculture, and finance. The correlation between MSOX and the US Cannabis ETF is designed to offer investors amplified exposure to the performance of the cannabis-related business sector.
MSOX SECTOR
The MSOX ETF focuses on the Pharmaceuticals, Biotechnology & Life Sciences Industry Group within the Health Care sector. This ETF targets companies involved in medical research, drug production, and other activities related to healthcare and life sciences. By concentrating its investments in this sector, the MSOX ETF provides investors with exposure to the dynamic and rapidly evolving field of pharmaceuticals and biotechnology, potentially benefiting from advancements in medical research and innovation.
MSOX EXPOSURE
The MSOS ETF (MSOX) focuses on providing investors with exposure to the U.S. cannabis industry. This actively managed fund aims to achieve returns that are two times (2x) the daily total return of the US Cannabis ETF, utilizing swap agreements. The US Cannabis ETF, which the fund seeks to track, invests in companies deriving significant revenue from the marijuana and hemp business in the United States, spanning various sectors including agriculture, biotechnology, pharmaceuticals, real estate, retail, and finance. As such, the MSOS ETF offers a concentrated exposure to the evolving landscape of cannabis-related businesses within these industries.